<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Pharmacy in jobs, news, schools</title>
	<link>http://pharmacy-in-jobs.pharmacy-bg.com</link>
	<description>Pharmacy jobs, news, articles, drugs info, pills</description>
	<lastBuildDate>Mon, 12 Dec 2011 11:20:28 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.2.1" -->

	<item>
		<title>Student Pharmacists to Receive National Community Engaged Service Award American Association of Colleges of Pharmacy (AACP)</title>
		<description><![CDATA[AACP Student Community Engaged Service Award will be awarded to four outstanding student-led community engagement programs delivering consumer education about medication use. These programs have been proven to expand access to affordable healthcare and dramatically improve the public’s health.
Teams from the University of Arkansas for Medical Sciences, University of California, San Francisco, Creighton University and [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-schools-university/2011/12/12/student-pharmacists-to-receive-national-community-engaged-service-award-american-association-of-colleges-of-pharmacy-aacp">Student Pharmacists to Receive National Community Engaged Service Award American Association of Colleges of Pharmacy (AACP)</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-schools-university/2011/12/12/student-pharmacists-to-receive-national-community-engaged-service-award-american-association-of-colleges-of-pharmacy-aacp?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=student-pharmacists-to-receive-national-community-engaged-service-award-american-association-of-colleges-of-pharmacy-aacp</link>
			</item>
	<item>
		<title>KLE University’s College of Pharmacy conducts National Pharmacy Week</title>
		<description><![CDATA[KLE University’s College of Pharmacy, Belgaum had chalked out a plan to create an awareness about the role of a pharmacist as a healthcare professional.    This was in accordance with this year’s National Pharmacy Week theme  “Pharmacist &#8212; a healthcare professional”  which was observed between Nov 21 to 26, 2011.
During the week-long celebrations, the  Indian [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-schools-university/2011/12/12/kle-university%e2%80%99s-college-of-pharmacy-conducts-national-pharmacy-week">KLE University’s College of Pharmacy conducts National Pharmacy Week</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-schools-university/2011/12/12/kle-university%e2%80%99s-college-of-pharmacy-conducts-national-pharmacy-week?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=kle-university%25e2%2580%2599s-college-of-pharmacy-conducts-national-pharmacy-week</link>
			</item>
	<item>
		<title>Culprits of Biotech&#8217;s Malaise: Let&#8217;s Also Look in the Mirror</title>
		<description><![CDATA[Malaise and despair seem to have taken over the biotech venture and startup community of late. “Venture’s stress” is the cover story of BioCentury.  Biotech VCs are so distraught they are taking the case to Washington DC to lament the fate of our industry.  Venture funds focused on life sciences have struggled to raise money, and several [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-news/2011/12/11/culprits-of-biotech-s-malaise-let-s-also-look-in-the-mirror">Culprits of Biotech&#8217;s Malaise: Let&#8217;s Also Look in the Mirror</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-news/2011/12/11/culprits-of-biotech-s-malaise-let-s-also-look-in-the-mirror?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=culprits-of-biotech-s-malaise-let-s-also-look-in-the-mirror</link>
			</item>
	<item>
		<title>FDA approves first diabetes-cholesterol combo pill</title>
		<description><![CDATA[TRENTON, N.J. (AP) &#8212; The first combination pill for the millions of people with the dangerous combination of diabetes and high cholesterol won U.S. approval Friday, offering convenience &#8212; and savings &#8212; to patients taking multiple pills.Juvisync, a probable blockbuster developed by Merck &#38; Co. Inc., will be launched in a few weeks. It combines [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-news/2011/12/11/fda-approves-first-diabetes-cholesterol-combo-pill">FDA approves first diabetes-cholesterol combo pill</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-news/2011/12/11/fda-approves-first-diabetes-cholesterol-combo-pill?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=fda-approves-first-diabetes-cholesterol-combo-pill</link>
			</item>
	<item>
		<title>UPDATE 2-Amgen signals R&amp;D changes to employees</title>
		<description><![CDATA[Employees are told changes are under evaluation
* Aims to improve focus, reallocate resources
Oct 12 (Reuters) &#8211; Amgen Inc , the world&#8217;s largest biotechnology company, has told its research and development staff it is evaluating changes in its R&#38;D programs, a company spokeswoman said on Wednesday.
The company told employees the changes would be aimed at improving [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-jobs/2011/12/11/update-2-amgen-signals-rd-changes-to-employees">UPDATE 2-Amgen signals R&#038;D changes to employees</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-jobs/2011/12/11/update-2-amgen-signals-rd-changes-to-employees?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=update-2-amgen-signals-rd-changes-to-employees</link>
			</item>
	<item>
		<title>Study: Orphan drugs win favored status in FDA reviews</title>
		<description><![CDATA[Over the last few years there&#8217;s been a big increase in Big Pharma&#8217;s interest in rare diseases. With Genzyme&#8217;s success with drugs like Myozyme helping light the way, giants like GlaxoSmithKline, Pfizer, Merck and Novartis have been organizing their own rare disease drug shops. And the FDA&#8217;s more flexible attitude in how it judges the data from [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-news/2011/12/11/study-orphan-drugs-win-favored-status-in-fda-reviews">Study: Orphan drugs win favored status in FDA reviews</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-news/2011/12/11/study-orphan-drugs-win-favored-status-in-fda-reviews?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=study-orphan-drugs-win-favored-status-in-fda-reviews</link>
			</item>
	<item>
		<title>Why Contract Research Organizations Are So Hot</title>
		<description><![CDATA[With more drugmakers outsourcing more trials to contract research organizations, few should be surprised that the CRO sector is generating investor interest. The attention-grabbing deal announced this week in which two private equity firms – Carlyle Group and Hellman &#38; Friedman – agreed to pay $3.9 billion in cash to buy Pharmaceutical Product Development is [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-jobs/2011/12/11/why-contract-research-organizations-are-so-hot">Why Contract Research Organizations Are So Hot</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-jobs/2011/12/11/why-contract-research-organizations-are-so-hot?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=why-contract-research-organizations-are-so-hot</link>
			</item>
	<item>
		<title>Lipitor &#8211; Why There Will Never Be Another Drug Like Lipitor</title>
		<description><![CDATA[Today, the U.S. patent expires on the Pfizer’s Lipitor, the best-selling drug of all time. The first generic versions will go for sale, marking the end of a brand that has dominated the drug industry, lowered the cholesterol of tens of millions of patients, and generated more in annual sales than Major League Baseball or [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-database/2011/12/04/lipitor-why-there-will-never-be-another-drug-like-lipitor">Lipitor &#8211; Why There Will Never Be Another Drug Like Lipitor</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-database/2011/12/04/lipitor-why-there-will-never-be-another-drug-like-lipitor?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=lipitor-why-there-will-never-be-another-drug-like-lipitor</link>
			</item>
	<item>
		<title>Pfizer&#8217;s Lipitor: How Big Pharma Blocks Reimbursement Of Generics</title>
		<description><![CDATA[Pfizer, Lipitor, Pharma Blocks, Generics

Good news! You learn that today, November 30, 2011, a generic version of Lipitor® is going on sale for the first time. You have been using Lipitor® as an adjunct to your diet to reduce your cholesterol, So you run down to the pharmacy and ask to have the generic atorvastatin, [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-database/2011/12/04/pfizer-s-lipitor-how-big-pharma-blocks-reimbursement-of-generics">Pfizer&#8217;s Lipitor: How Big Pharma Blocks Reimbursement Of Generics</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-database/2011/12/04/pfizer-s-lipitor-how-big-pharma-blocks-reimbursement-of-generics?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pfizer-s-lipitor-how-big-pharma-blocks-reimbursement-of-generics</link>
			</item>
	<item>
		<title>Ranbaxy’s Lipitor Generic Approved by U.S. FDA, Threatening Pfizer Sales</title>
		<description><![CDATA[Ranbaxy, Lipitor Generic, FDA, Pfizer, Pfizer Sales
Ranbaxy Laboratories Ltd. (RBXY)’s copy of the $10.7 billion Lipitor cholesterol pill was released in the U.S., sending its share up the most in six months and threatening sales for Pfizer Inc. (PFE)
Ranbaxy, India’s biggest drugmaker, won approval to sell generic versions of the world’s top-selling medicine by the [...]<p><a href="http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-database/2011/12/04/ranbaxy%e2%80%99s-lipitor-generic-approved-by-u.s.-fda-threatening-pfizer-sales">Ranbaxy’s Lipitor Generic Approved by U.S. FDA, Threatening Pfizer Sales</a> is a post from: <a href="http://pharmacy-in-jobs.pharmacy-bg.com">Pharmacy in jobs, news, schools</a></p>
]]></description>
		<link>http://pharmacy-in-jobs.pharmacy-bg.com/pharmacy-database/2011/12/04/ranbaxy%e2%80%99s-lipitor-generic-approved-by-u.s.-fda-threatening-pfizer-sales?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ranbaxy%25e2%2580%2599s-lipitor-generic-approved-by-u.s.-fda-threatening-pfizer-sales</link>
			</item>
</channel>
</rss>

